Best Read Articles on News Not Related to COVID-19 in 2021
Apotex's importation of Chantix (varenicline) and Express Scripts' formulary exclusions were among the best read articles this year that didn't concern COVID-19.
FDA Approves Generic of Chantix, Pfizer's Smoking Cessation Drug
This is the first approval of generic version of Chantix, and it comes just weeks after a recall of the brand-name drug.
Apotex to Import Generic of Chantix from Canada
This is being done in coordination with the FDA to address the shortage created by the recall of Chantix.
Express Scripts Releases List of 2022 Formulary Exclusions
Four products on the preferred list this year will be excluded next year.
Nonopioid Pain Therapeutic Achieves More Than 100 Formulary Approvals
Anjeso, a COX-2 inhibito, is a faster-acting injectable formulation of meloxicam. As amnm alternative to opiods, it reduces opioid use after surgery.
FDA approves sNDAs for Vazalore
Application was submitted for both the 81 and 325 mg doses of the liquid-filled capsule formulation of aspirin.
Capricor Completes BLA for Deramiocel for Duchenne Cardiomyopathy
January 3rd 2025Deramiocel is a cell therapy that has healing effects in muscle cells. If approved, deramiocel would be a once-quarterly therapy and the first specifically approved for cardiomyopathy in patients with Duchenne muscular dystrophy.
Read More
